KDM1A and neoplasm: Inhibitors of LSD1 and BET exhibit potent synergistic effects, inducing tumor growth inhibition by disrupting the activity of multiple driver genes in CRPC.[40] A set of aberrantly activated super‐enhancers identified in Enzalutamide‐resistant CRPC cells.